Commercialization & growth.
Integrated scientific, strategic, and market expertise that drives value.
How we help.
Our commercialization & growth offering brings together scientific depth, market intelligence, and strategic expertise to guide products and franchises at every stage of the lifecycle. We help organizations define where to play and how to win by connecting insights, analytics, and real-world dynamics into a unified path forward. From early development through in-line performance, we create integrated strategies that accelerate growth and strengthen long-term value.
- Shape product, brand, and franchise strategies that connect science, market insight, and execution.
- Integrate commercial, Medical Affairs, and access expertise supported by strong data and analytics.
- Maximize performance across the lifecycle through investment decisions, launch strategies, and value sustainment.
Some of our experts.
Karan Raje, Partner
Karan sits on Putnam’s Commercial Practice Leadership team, advising US and European biopharma on pipeline and in-line products. His focus includes go-to-market strategy, opportunity assessment, forecasting, and portfolio optimization.
John Gordon, Partner
John has 30+ years of strategy consulting experience, advising pharma and biotech executives on pricing, contracting, reimbursement, corporate strategy, product commercialization, clinical trial development, and sales force optimization.
Vikram Gosain, Partner
Vikram is a partner in Putnam’s London office, expanding the commercial strategy practice in the UK and Europe. With 20+ years of consulting experience, he helps global clients make informed decisions across asset, disease, and portfolio strategy.
Mariah Hanley, Partner
Mariah translates insights from primary and secondary research into clear strategic guidance across neurology, rare diseases, oncology, and vaccines. She brings deep expertise in qualitative and quantitative methods and actionable insight development.
Lori Klein, Partner, Medical and Scientific Affairs Practice Lead
Lori’s expertise spans stakeholder engagement, center-of-excellence profiling, organizational design, strategic medical launches, integrated evidence planning, omnichannel strategy, and digital health platforms including digital therapeutics, AI, and software as a medical device.
Insights & latest.
Access the most up-to-date health and life sciences insights and resources.
-
Thought LeadershipRead more
Unlocking Patient Insights in HEOR Through Netnography: A Scalable Qualitative Research Method
In pharma commercialization, AI and analogs set the stage, but human insight drives strategies that break precedent and win markets
-
Thought LeadershipRead more
AI as the Input, Not the Answer: When Human Strategy Still Leads
In pharma commercialization, AI and analogs set the stage, but human insight drives strategies that break precedent and win markets
-
Thought LeadershipRead more
Key 2025 ASCO® Outcomes
CAR-T innovation in solid tumors shows mixed results at ASCO® 2025, progress seen, but safety, delivery & durability challenges remain.
-
Case StudiesRead more
A Deeper, Foundational Understanding of the IBD Patient Journey
Integrated research uncovered nuanced patient journeys and treatment shifts to guide clinical strategy and avoid portfolio cannibalization
Connect.
Let’s discuss how we can help you.